Fortsätter med en studie där man sett att MS-patienter har en fler celler kopplade till autoimmunitet i tarmen, mer specifikt Th17- och Th22-celler.

“Our data suggest that there is a selective activation of Th17 cells in the intestinal mucosa of MS patients. These findings validate previous reports in pre-clinical models of MS and provide the first evidence that gut immunity modulate MS pathogenesis in humans.”

Forskarna vill nu testa om omvärldsfaktorer kan påverka sjukdomen:

“Our next goal is to determine how environmental factors such as diet can modulate MS pathogenesis through alterations of gut microbiota composition and intestinal immunity.”